Please login to the form below

Not currently logged in


This page shows the latest rights news and features for those working in and with pharma, biotech and healthcare.

Lucid Group acquires HealthCare21

Lucid Group acquires HealthCare21

Expands reach in UK, Asia Pacific and Middle East. From left to right: Cliff Wyatt, HealthCare21 managing director, Jan Steele, Lucid Group COO and co-founder and Dennis O’Brien, Lucid

Latest news

More from news
Approximately 2 fully matching, plus 2,297 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 487 partially matching documents found.

Latest appointments

  • Streaming Well to “raise the bar in pharma film making” Streaming Well to “raise the bar in pharma film making”

    Steve Skinner (pictured right) joins Streaming Well as the company’s new Creative Director.

  • New hires at Ferring, Flexion and Immunocore New hires at Ferring, Flexion and Immunocore

    management team with the right scientific and leadership expertise to move the organisation forward”.

  • Weekly industry appointments Weekly industry appointments

    Gelesis adds to company. Biotech Gelesis has bolstered its offering with the addition of Harry Leider (pictured top right), former chief medical officer and group vice president of pharmacy company Walgreens. ... Also joining the company is Boehringer

  • Weekly comms appointments Weekly comms appointments

    Sarah Winterbottom joins ROAD. Independent healthcare communications specialist ROAD has appointed Sarah Winterbottom (pictured right) as senior director. ... W2O appoints Ujwal Pyati. W2O, a network of analytics-driven, digital marketing communications

  • Novartis changes executive committee Novartis changes executive committee

    Narasimhan, said: “Robert’s deep understanding of business services coupled with his strong financial and commercial acumen make him the right person to lead NBS in the next stage of its

More from appointments
Approximately 0 fully matching, plus 235 partially matching documents found.

Latest from PMHub

  • Programmatic methodology and why you should be using it

    This is all anonymised data and allows us to target the right user for the right campaign. ... With our partners we are building a network of HCP related sites that would mean that we have the right audiences.

  • Can you survive without the blue dot?

    OK, I did not say the last bit. My colleague, more usefully, told him which tube line to take and pointed out that if he didn't have the right phone ... In fact, where has he been, or where is he from, to automatically expect that kind of interaction

  • Clark Health Communications and Egg digital announce new collaboration

    This exciting alliance with Egg allows us to bring digital solutions right into the heart of our current thinking, planning and delivery but also to future proof our capability knowing that

  • Don’t just hope: COPE

    right place, in the right format, and at the right time to maximise return on often-limited investment. ... Using COPE, content can be adapted for different needs and contexts, to give users the right content in the right format.

  • How to dramatically increase ROI on your eDetailing content

    New technologies and Anthill knowhow actually make this quite simple – so you can act quickly to dramatically raise the level of service that you’re providing HCPs right now.

More from PMHub
Approximately 0 fully matching, plus 445 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...